This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NeoStem To Present At Multiple January Conferences

NEW YORK, Jan. 2, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company and its subsidiary, Progenitor Cell Therapy, LLC ("PCT"), will present at multiple upcoming conferences in January.

ECI's Scale-Up and Manufacturing of Cell-Based Therapies III
  • Date and Time: Tuesday, January 7, 2014, 3:05 PM PST
  • Venue: Hyatt Regency, San Diego, California
  • Session: Engineering a process for commercial success – strategic considerations and technology alternatives
  • Speaker: Brian Hampson, MS, Senior Director, Engineering & Innovation of PCT

Biotech Showcase 2014
  • Date and Time: Monday, January 13, 2014, 11:30 AM PST
  • Venue: Parc 55 Wyndham San Francisco – Union Square, San Francisco, California
  • Session: Company Presentation
  • Speaker: Robert A. Preti, PhD, President of PCT, Chief Scientific Officer of NeoStem

7 th Annual OneMedForum
  • Venue: The Westin San Francisco Market Street, San Francisco, California
  • Presentation Topics: Company Presentations
  • Presentation #1 Date and Time: Monday, January 13, 2014, 11:50 AM PST
  • Presentation #1 Speaker: Robin L. Smith, MD, MBA, Chairman and CEO of NeoStem
  • Presentation #2 Date and Time: Tuesday, January 14, 2014, 9:50 AM PST
  • Presentation #2 Speaker: Andrew L. Pecora, MD, FACP, Chief Visionary Officer of NeoStem

Alliance for Regenerative Medicine's 4 th Annual State of the Industry Briefing
  • Date and Time: Monday, January 13, 2014, 8:00 AM PST
  • Venue: Parc 55 Wyndham San Francisco – Union Square, San Francisco, California
  • Session: Key Clinical Data Inflection Points for 2014 Panel
  • Panelist: Andrew L. Pecora, MD, FAHA, Chief Visionary Officer of NeoStem

Noble Financial Capital Markets Tenth Annual Equity Conference
  • Date and Time: Monday, January 20, 2014 at 10:00 AM EST
  • Venue: Club Med Sandpiper Bay, Sandpiper Bay, Florida
  • Session: Company Presentation
  • Moderator: Robin L. Smith, MD, MBA, Chairman and CEO of NeoStem

Ninth International Conference on Cell Therapy for Cardiovascular Disease
  • Venue: Vivian and Seymour Milstein Family Heart Center, New York, New York
  • Session #1 Date and Time: Thursday, January 23, 2014, 9:28 AM EST
  • Session #1: AMR-001 and PreSERVE Study: Autologous CD34+ Cells for AMI
  • Session #1 Speaker: Jonathan Sackner-Bernstein, MD, FACC, Vice President, Clinical Development of NeoStem
  • Session #2 Date and Time: Friday, January 24, 2014, 10:30 AM EST
  • Session #2: Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine
  • Session #2 Discussant: Douglas W. Losordo, MD, FACC, FAHA, Chief Medical Officer of NeoStem

About NeoStem, Inc.

NeoStem, Inc. is a leader in the emerging cellular therapy industry. Our business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs